Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition

Cancer Cell

Volumn 15, Issue 5, 2009, Pages 402-415

  Evdokimova, Valentina ^a,b   Tognon, Cristina ^c   Ng, Tony ^c   Ruzanov, Peter ^d   Melnyk, Natalya ^c   Fink, Dieter ^c   Sorokin, Alexey ^b   Ovchinnikov, Lev P ^b   Davicioni, Elai ^e   Triche, Timothy J ^f   Sorensen, Poul H B ^a,c  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b INSTITUTE OF PROTEIN RESEARCH   (Russian Federation)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Children's Hospital Los Angeles ^*  (United States)

^f CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

CELLCYCLE

Indexed keywords

CAP BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN; Y BOX BINDING PROTEIN 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYME CELL; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

EID: 65349116534     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2009.03.017     Document Type: Article

References (41)

1. Abdueva D., Wing M.R., Schaub B., and Triche T.J. Experimental comparison and evaluation of the Affymetrix exon and U133Plus2 GeneChip arrays. PLoS ONE 2 (2007) e913
2. Bader A.G., and Vogt P.K. Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation. Mol. Cell. Biol. 25 (2005) 2095-2106
3. Bader A.G., and Vogt P.K. Phosphorylation by AKT disables the anti-oncogenic activity of YB-1. Oncogene 27 (2007) 1179-1182
4. Barrallo-Gimeno A., and Nieto M.A. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132 (2005) 3151-3161
5. Beretta L., Gingras A.C., Svitkin Y.V., Hall M.N., and Sonenberg N. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15 (1996) 658-664
6. Bergmann S., Royer-Pokora B., Fietze E., Jurchott K., Hildebrandt B., Trost D., Leenders F., Claude J.C., Theuring F., Bargou R., et al. YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification. Cancer Res. 65 (2005) 4078-4087
7. Brackstone M., Townson J.L., and Chambers A.F. Tumor dormancy in breast cancer: an update. Breast Cancer Res. 9 (2007) 208
8. Cobbold L.C., Spriggs K.A., Haines S.J., Dobbyn H.C., Hayes C., de Moor C.H., Lilley K.S., Bushell M., and Willis A.E. Identification of IRES-trans-acting factors for the Myc family of IRESs. Mol. Cell. Biol. 28 (2007) 40-49
9. Davicioni E., Finckenstein F.G., Shahbazian V., Buckley J.D., Triche T.J., and Anderson M.J. Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas. Cancer Res. 66 (2006) 6936-6946
10. Dawson P.J., Wolman S.R., Tait L., Heppner G.H., and Miller F.R. MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am. J. Pathol. 148 (1996) 313-319
11. Debnath J., and Brugge J.S. Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer 5 (2005) 675-688
12. Debnath J., Muthuswamy S.K., and Brugge J.S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30 (2003) 256-268
13. Evdokimova V.M., and Ovchinnikov L.P. Translational regulation by Y-box transcription factor: involvement of the major mRNA-associated protein, p50. Int. J. Biochem. Cell Biol. 31 (1999) 139-149
14. Evdokimova V., Ruzanov P., Imataka H., Raught B., Svitkin Y., Ovchinnikov L.P., and Sonenberg N. The major mRNA-associated protein YB-1 is a potent 5′ cap-dependent mRNA stabilizer. EMBO J. 20 (2001) 5491-5502
15. Evdokimova V., Ovchinnikov L.P., and Sorensen P.H. Y-box binding protein 1: providing a new angle on translational regulation. Cell Cycle 5 (2006) 1143-1147
16. Evdokimova V., Ruzanov P., Anglesio M.S., Sorokin A., Ovchinnikov L., Buckley J., Triche T.J., Sonenberg N., and Sorensen P.H.B. AKT-mediated YB-1 phosphorylation activates translation of silent mRNA species. Mol. Cell. Biol. 26 (2006) 277-292
17. Garcia-Gasca A., and Spyropoulos D.D. Differential mammary morphogenesis along the anteroposterior axis in Hoxc6 gene targeted mice. Dev. Dyn. 219 (2000) 261-276
18. Gupta G.P., and Massagué J. Cancer metastasis: building a framework. Cell 127 (2006) 679-695
19. Janz M., Harbeck N., Dettmar P., Berger U., Schmidt A., Jurchott K., Schmitt M., and Royer H.D. Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1. Int. J. Cancer 97 (2002) 278-282
20. Jimenez J., Jang G.M., Semler B.L., and Waterman M.L. An internal ribosome entry site mediates translation of lymphoid enhancer factor-1. RNA 11 (2005) 1385-1399
21. Katoh M. WNT/PCP signaling pathway and human cancer. Oncol. Rep. 14 (2005) 1583-1588
22. Kohno K., Izumi H., Uchiumi T., Ashizuka M., and Kuwano M. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25 (2003) 691-698
23. Korsching E., Jeffrey S.S., Meinerz W., Decker T., Boecker W., and Buerger H. Basal carcinoma of the breast revisited: an old entity with new interpretations. J. Clin. Pathol. 61 (2008) 553-560
24. Lang K.J., Kappel A., and Goodall G.J. Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol. Biol. Cell. 13 (2002) 1792-1801
25. Lu Z.H., Books J.T., and Ley T.J. YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence. Mol. Cell. Biol. 25 (2005) 4625-4637
26. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 (2008) 704-715
27. Mejlvang J., Kriajevska M., Vandewalle C., Chernova T., Sayan A.E., Berx G., Mellon J.K., and Tulchinsky E. Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol. Biol. Cell. 18 (2007) 4615-4624
28. Moody S.E., Perez D., Pan T.C., Sarkisian C.J., Portocarrero C.P., Sterner C.J., Notorfrancesco K.L., Cardiff R.D., and Chodosh L.A. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8 (2005) 197-209
29. Nelson C.M., and Bissell M.J. Modeling dynamic reciprocity: engineering three-dimensional culture models of breast architecture, function, and neoplastic transformation. Semin. Cancer Biol. 15 (2005) 342-352
30. Peinado H., Quintanilla M., and Cano A. Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J. Biol. Chem. 278 (2003) 21113-21123
31. Peinado H., Olmeda D., and Cano A. Snail, Zeb and bHLH factors in tumor progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 7 (2007) 415-428
32. Rae J.M., Creighton C.J., Meck J.M., Haddad B.R., and Johnson M.D. MDA-MB-435 cells are derived from M14 melanoma cells-a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res. Treat. 104 (2007) 13-19
33. Sorokin A.V., Selyutina A.A., Skabkin M.A., Guryanov S.G., Nazimov I.V., Richard C., Th'ng J., Yau J., Sorensen P.H.B., Ovchinnikov L.P., and Evdokimova V. Proteasome-mediated cleavage of the Y-box binding protein 1 is linked to DNA-damage stress response. EMBO J. 24 (2005) 3602-3612
34. Stoneley M., and Willis A.E. Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression. Oncogene 23 (2004) 3200-3207
35. Stoneley M., Spencer J.P., and Wright S.C. An internal ribosome entry segment in the 5′ untranslated region of the mnt gene. Oncogene 20 (2001) 893-897
36. Stratford A.L., Habibi G., Astanehe A., Jiang H., Hu K., Park E., Shadeo A., Buys T.P., Lam W., Pugh T., et al. Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy. Breast Cancer Res. 9 (2007) R61
37. Sutherland B.W., Kucab J., Wu J., Lee C., Cheang M.C., Yorida E., Turbin D., Dedhar S., Nelson C., Pollak M., et al. AKT phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene 24 (2005) 4281-4292
38. Thiery J.P., and Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7 (2006) 131-142
39. Toyo-oka K., Bowen T.J., Hirotsune S., Li Z., Jain S., Ota S., Escoubet-Lozach L., Garcia-Bassets I., Lozach J., Rosenfeld M.G., et al. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression. Cancer Res. 66 (2006) 5565-5573
40. Vega S., Morales A.V., Ocaña O.H., Valdés F., Fabregat I., and Nieto M.A. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev. 18 (2004) 1131-1143
41. Yang J., Mani S.A., and Weinberg R.A. Exploring a new twist on tumor metastasis. Cancer Res. 66 (2006) 4549-4552